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ABSTRACT
Objectives: To develop a new model for patient
recruitment that harnessed the full potential of
Electronic Health Records (EHRs). Gaining access to
potential participants’ health records to assess their
eligibility for studies and allow an approach about
participation (‘consent for contact’) is ethically, legally
and technically challenging, given that medical data are
usually restricted to the patient’s clinical team. The
research objective was to design a model for
identification and recruitment to overcome some of
these challenges as well as reduce the burdensome
(and/or time consuming) gatekeeper role of clinicians
in determining who is appropriate or not to participate
in clinical research.
Setting: Large secondary mental health services
context, UK.
Participants: 2106 patients approached for ‘consent
for contact’. All patients in different services within the
mental health trust are gradually and systematically
being approached by a member of the clinical care
team using the ‘consent for contact’ model. There are
no exclusion criteria.
Primary and secondary outcome measures:
Provision of ‘consent for contact’.
Results: A new model (the South London and
Maudsley NHS Trust Consent for Contact model (SLaM
C4C)) for gaining patients’ consent to contact them
about research possibilities, which is built around a
de-identified EHR database. The model allows
researchers to contact potential participants directly.
Of 2106 patients approached by 25 October 2013,
nearly 3 of every 4 gave consent for contact (1560
patients; 74.1%).
Conclusions: The SLaM C4C model offers an
effective way of expediting recruitment into health
research through using EHRs. It reduces the
gatekeeper function of clinicians; gives patients greater
autonomy in decisions to participate in research; and
accelerates the development of a culture of active
research participation. More research is needed to
assess how many of those giving consent for contact
subsequently consent to participate in particular
research studies.
INTRODUCTION
Recruiting patients into health research
One of the most pressing issues for research-
ers needing to recruit patients is how best to
identify who might be suitable for their
research, at the same time as adhering to
legal and ethical frameworks regarding conﬁ-
dentiality and privacy. Medical data are, in
multiple jurisdictions, generally accessible to
researchers only with prior patient consent,
or if the data are adequately de-identiﬁed;
this means, in short, that a researcher needs
to gain consent from an individual before
accessing her personal details to adjudicate
suitability for the research and before contact-
ing her to ask about potential participation.
Access to individuals’ medical records is
usually restricted to members of the clinical
team, who thereby act as intermediaries
through which contact between researchers
and potential research participants is com-
monly made. Such a process is, however,
often cumbersome and time-consuming: busy
clinical teams often do not have the time to
assist with recruitment; the alternative path of
Strengths and limitations of this study
▪ A new model for gaining patients’ consent to
contact them about research possibilities, which
is built around a robustly de-identified Electronic
Health Records (EHR) database.
▪ Currently, three of every four patients
approached are giving consent to contact using
the model.
▪ The model gives patients greater autonomy in
decisions about research participation.
▪ The model was developed through extensive
patient/service user involvement and consultation.
▪ The study does not examine whether patients who
have given consent to contact go on to consent to
participation in particular research studies.
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writing to each patient (eg, within a general practice) to
ask if she would agree to researchers accessing her
medical records to assess suitability for a study is no less
onerous. Furthermore, should the clinician still be a gate-
holder for the patient? Is this not a remnant of medical
paternalism, outdated in today’s healthcare system and
research context with citizen science and
direct-to-consumer research opportunities such as the
uBiome1 project? Clinicians’ desire to protect patients
can, through ‘gatekeeping’, end up effectively denying
them the opportunity to participate in research.2 Such a
problem is particularly pertinent within a mental health
context. In short, it is time to allow patients greater auton-
omy in decisions to take part in research by reducing the
gatekeeper role of clinicians—not least because such
gatekeeper functions can exacerbate inequities in who is
able to participate in health research.
Amidst wide concern about difﬁculties in recruiting to
clinical studies,3 there are calls to transform the culture
of patient participation in health research (eg, US
National Institutes of Health (NIH) Road Map,4 and
England’s National Health Service (NHS)
Constitution).5 The inﬂuential 2008 Data Sharing
Review in the UK recommended that ‘The NHS should
develop a system to allow approved researchers to work
with healthcare providers to identify potential patients,
who may then be approached to take part in clinical
studies for which consent is needed’.6 There appears,
however, to be a reluctance to mandate legislatively a
move away from the current model in which researchers
require consent before accessing medical records.
Meanwhile, quantitative and qualitative studies in a
number of countries have indicated that signiﬁcant pro-
portions of the public are cautious about giving
researchers access to their medical records for recruit-
ment purposes without prior consent, even as the public
remains supportive of health research.7–9 A mass public
engagement exercise (6000 people) in England, for
example, found that only 34% of adults and 10% of
young people agreed with extending the range of
people with direct access to patient records to assist in
recruitment to clinical trials.10 Given this and the
current legislative environment, it is likely that in the
UK, at least, the current principles surrounding consent
(ie, that researchers are not able to access a patient’s
records without consent unless they are a member of
the patient’s clinical team) will continue to underpin
research governance for some time. There is therefore a
need to ﬁnd ways of negotiating this governance envir-
onment that would allow more efﬁcient identiﬁcation
of, and better engagement with, potential research parti-
cipants, and would empower patients or service users to
make their own decisions regarding which, if any,
research projects to learn more about.11–13
Consent for contact
One response to this challenge has been the formula-
tion of what has, in the last decade, come to be termed
‘consent for contact’ or ‘consent to consent’. This, as
the Academy of Medical Sciences puts it, comprises a
‘mechanism … for individuals to give generic consent to be
contacted about suitable research opportunities, before consid-
ering whether they consent to take part in a speciﬁc
study’ [italics added].14 Notably, ‘consent for contact’
processes are being put in place in a range of health
research facilities. A project in British Columbia, Canada
has, since 2007, set up ‘Permission to Contact’ platforms
in different outpatient health clinics (cancer, cardiac
and maternal health), which have proved effective in
enhancing enrolment into translational research pro-
jects.15 16 In the UK, the UK Biobank project requires
explicit consent in order both to access the medical
records of those joining the project, as well as potentially
to recontact these participants in the future.17 While
such generic consent is appealing for researchers, its
operationalisation poses a number of ethical, socio-
logical, governance-related and technical questions
(box 1). There is growing interest in how EHRs might
be used in this regard. To date, the use of EHRs for
recruitment has relied on mechanisms through which a
member of the clinical team of the patient identiﬁed—
via pseudonymised searching—as potentially eligible for
the study is alerted and invited to contact that patient.
Such use therefore currently maintains the distinction
between those designing the studies and those recruiting
into the studies.18–22
That many of the questions surrounding the use of
EHRs for research remain unresolved, at a conceptual
and an empirical level, is demonstrated by the number
of medical, bioethical and governance-oriented bodies
currently reﬂecting on them.14 23–25 Our paper takes
these discussions forward through focusing on an
Box 1 ‘Consent for contact’: sociological, ethical and
technical issues
▸ How does ‘consent for contact’ reshape relationships between
treating clinicians, patients and researchers—in that the trad-
itional role of clinician (as patient advocate and/or paternalistic
patient protector) in relation to the researcher is downgraded
in the emergence of a new kind of compact between patient
and researcher?
▸ How does patients’ giving of generic consent to be contacted
affect how they subsequently respond to invitations to partici-
pate in specific research projects (ie, do they feel more of an
onus to give consent here, too, having given consent once
already)?
▸ Does ‘consent for contact’ encourage an assumption that will-
ingness to participate in health research is a moral obligation
—and if so, what are the ethical, clinical and sociological
implications?
▸ How can Electronic Health Records be best used in developing
consent for contact procedures? How should their use navi-
gate complex questions regarding control, ownership and use
of such data in relation to consent, authorisation and
safe-keeping?
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empirical advance: the model of consent for contact
developed by the South London and Maudsley (SLaM)
NHS Foundation Trust (hereafter: SLaM C4C). For
whatever one’s position regarding the merits or demerits
of ‘consent for contact’, it is commonly agreed that
‘further work is needed to provide guidance and models
to enable appropriate access and identiﬁcation of
patients for research’.26 SLaM C4C was endorsed by the
UK’s Information Governance Review in 2013 as an
exemplar of ‘an approach that allows appropriate indivi-
duals to be identiﬁed and approached to take part,
without giving researchers direct access to identiﬁable
information before consent is obtained’.24
In the paper we present: (1) the speciﬁcs of SLaM
C4C, which we believe to be the ﬁrst successful imple-
mentation of consent for contact which both harnesses
the potential of de-identiﬁed Electronic Health Records
(EHRs) to expedite recruitment to research, and allows
researchers to contact potential participants directly; (2)
descriptive statistics on how SLaM C4C is being received
by patients.
METHODS
The SLaM C4C model
SLaM C4C is designed to enhance patients’ access to
opportunities to participate in research projects of inter-
est to them (England’s NHS Constitution pledges ‘to
inform [patients] of research studies in which [they]
may be eligible to participate’).5 It also enables research-
ers to identify and approach potentially eligible people.
(These researchers have undergone rigorous approval
procedures, which include being bound by the duties
associated with a contract with King’s Health Partners
[an Academic Health Sciences Centre], which in turn
involves various Human Resources checks, including a
criminal record check in accordance with national
Department of Health standards). The model comprises
technical and procedural elements built into the EHR
case register at the NIHR Specialist Biomedical Research
Centre for Mental Health at the South London &
Maudsley (SLaM) NHS Foundation Trust (hereafter:
SLaM BRC). It was designed for use across SLaM, which
is one of the largest mental healthcare providers in
Europe, serving a local population of 1.2 million people,
and including inpatient wards, outpatient and commu-
nity services. Prior to this initiative, recruitment to clin-
ical research in SLaM relied on the traditional system of
researchers ﬁnding clinicians who were willing to iden-
tify and approach potential participants. Such nurse,
medical and other clinicians may have little or no train-
ing in research and scant knowledge of any particular
research programme; or they may themselves be
researchers. This, together with clinical pressures and
conﬂicting demands on time, result at best in the possi-
bility of biased recruitment and, at worse, limit recruit-
ment to research and obstruct patients from making
decisions about participation.
The model is embedded within a search and database
system (the Clinical Record Interactive Search [CRIS]),
which reads and extracts information from SLaM’s
EHRs, removes identiﬁers and makes this available to
researchers in de-identiﬁed format in standard analysis
packages (eg, Stata, Excel). Data consist of all clinical
records on SLaM patients (unless they have requested to
opt out from the register) and are searchable as both
structured and free text. There are currently over
250 000 cases on the database, which increases by
approximately 20 000 per year. We have described the
development and characteristics of CRIS elsewhere;27
there is also published research based on analyses of
CRIS data.28 We present the features of CRIS that allow
research participant recruitment.
Reverse search
The case register was initially approved for use as a
de-identiﬁed database whose data are searchable without
consent by appropriately vetted researchers. The evalu-
ation of this de-identiﬁcation procedure demonstrated
that CRIS effectively ensures patient anonymity at the
same time as maximises data (free text and structured
text) that are available for research. Indeed, our
bespoke pattern matching de-identiﬁcation algorithm
(which is applied to all structured and free text in CRIS)
was shown, when evaluated, to mask patient identiﬁers
with 98.8% precision and 97.6% recall—outperforming
a comparator machine learning algorithm. (We have
published a full description of the algorithm and the
evaluation data.)29 The register’s technical architecture
included, additionally, the potential for reverse search:
allowing the identiﬁcation of patients who meet given
characteristics (which can be deﬁned using structured
and free text), and thereby the possibility of using CRIS
to identify and approach potential participants on the
basis of prior consent by individual patients or, for chil-
dren or adults lacking capacity, an appropriate proxy. In
effect, such a mechanism allows for the creation within
the case register of a database of people (‘the recruit-
ment database’) who have provided prior consent to be
contacted and whose full—but de-identiﬁed—clinical
records will be available to a researcher (a ‘recruiter’) in
order to search for inclusion/exclusion criteria for spe-
ciﬁc, ethically approved studies. The researcher, once
they have identiﬁed eligible potential participants, can
then be given identiﬁers to access the source EHRs and
approach patients about participation in that particular
study (ﬁgure 1).
We have developed robust procedural mechanisms to
address legal and ethical requirements and to comple-
ment this process and technical design, which we brieﬂy
outline below.
Acquiring and recording consent for contact
▸ The consent process for participation in the recruit-
ment database is conducted by the patient’s clinical
team, most commonly by the patient’s care
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coordinator (or, if not, by another member of the
patient’s care team). The process is carried out face
to face. The SLaM C4C process is, additionally, being
publicised across the Trust. If a SLaM patient
expresses an interest in joining the C4C recruitment
database by contacting a member of the SLaM C4C
project team, that project worker (who is based in a
clinical team and bound by the same information
governance requirements as clinicians) is able to
carry out the consent procedures. In addition, the
patient’s own care coordinator or equivalent clinician
will be informed to check that there are no reasons
why that patient should not be included, as well as
encouraged to ﬁll out the research participation form
within the patient’s electronic health record. In other
words, there is always clinician involvement in the
process of consenting a patient on to the C4C
recruitment database. The member of the clinical
care team requesting consent receives training in the
speciﬁcs of the SLaM C4C model and on how best to
conduct the conversation clearly in a way that does
not place undue pressure on the patient.
▸ Clinical staff are trained in research governance (par-
ticularly regarding consent and the assessment of
mental capacity to provide consent) and the speciﬁc
process of acquiring ‘consent for contact’. The
process, supported by an information sheet (see
online supplementary appendices 1a–c), emphasises
that patients are not being asked for consent to par-
ticipate in any particular study—simply to being con-
tacted in the future by researchers about potential
participation in speciﬁed research projects based on
information in their full SLaM EHR. The clinician
explains, as required, more about what research is
Figure 1 The South London and Maudsley (SLaM) ‘consent for contact’ model.
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and what it might entail; what tends to be recorded
in an EHR; and reminds the patient that, if she con-
sents, she might be asked to participate in research
on different topics from those relating to her current
treatment. A research study has been conducted to
investigate how SLaM C4C consent conversations are
carried out by clinicians and to ascertain which kinds
of explanations of the recruitment database appear
to make it more or less likely that patients will give
their consent.30
▸ For patients who are children, or adults lacking cap-
acity (where the lack of capacity is believed to be per-
manent), proxy assent is sought from a close friend
or relative (with parental responsibility in the case of
children; see online supplementary appendices 1b
and 1c). The model is attentive to the mental health
context for which it was designed: where mental cap-
acity is thought to be temporarily absent, the clinical
team does not ask for consent, but aims to approach
the patient at a later time in accordance with the
second principle of the Mental Capacity Act.31
▸ The approach made by a clinician requesting consent
for contact is tailored to the clinical context—for
example, the request may be delayed for a distressed
patient admitted in a crisis.
▸ A research participation form has been created as an
additional window in the source clinical records
system (ﬁgures 2 and 3). This includes:
– Whether a C4C discussion has taken place with the
patient (or a named proxy);
– Whether the patient (or proxy) gave consent or
not;
– The name of the clinical staff member discussing
C4C and the date discussed;
– A free text box to record any further information.
Notably, patients are encouraged to identify any par-
ticular preferences regarding research opportunities
—both those that they would be particularly inter-
ested in, and kinds of research, or research topics,
that they would not want to be contacted about.
▸ For patients who have consented to being contacted,
the research participation form is also used to record
all subsequent contacts made by researchers, and all
projects the patient is participating in, has partici-
pated in, and/or has declined to participate in. If a
patient withdraws consent to be contacted then the
technical ability to link to his or her EHR ID will be
prevented.
▸ The model acknowledges that patients might not be
aware, at the point of giving consent to participating
Figure 2 Screen shot of the South London and Maudsley NHS Trust Consent for Contact model (SLaM C4C) Patient
Participation Form in the original source Electronic Health Record (EHR; part I).
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in the recruitment database, what information will
later be contained in their medical record. All con-
sents are revisited with the participant at the point of
discharge from all SLaM services or else are deemed
to have expired.
Identifying and contacting potential research participants
▸ In order to become a ‘recruiter’—that is, have the
ability to access CRIS for approaching potential
research participants—the researcher must have a sub-
stantive or honorary contract with SLaM and be an
employee of one of the organisations forming King’s
Health Partners, the Academic Health Sciences
Centre (AHSC) of which SLaM is a member. Use of
CRIS for all forms of research is logged and audited
and misuse would result in disciplinary action.
▸ Recruiters use de-identiﬁed data on CRIS to identify
potential recruits. In CRIS itself, records are identiﬁed
by a locally generated pseudonym (the Biomedical
Research Centre ID; BRC ID). This pseudonym is
linked to the EHR ID number in the building of the
CRIS data repository. Research users of CRIS are
unable to access the link between BRC ID and EHR ID
(ﬁgure 1), which maintains the integrity of CRIS as a
de-identiﬁed database.
▸ An Oversight Committee (which is chaired by a
mental health patient) manages all access to, and
monitors all use of, CRIS, and reports to the Trust
Caldicott Committee (which has responsibility for
ensuring the protection of patient conﬁdentiality
throughout the Trust). The committee provides oper-
ational oversight and management of CRIS—includ-
ing the provision of research governance for projects
using CRIS; the monitoring and regular review of the
effectiveness of the CRIS security model (including
the de-identiﬁcation processes); oversight of the
administration of CRIS, including access control and
maintenance, as well as the monitoring of audit logs;
provision of advice on how to use CRIS; and
responses to complaints related to CRIS (including
from patients). There is no quorum required for indi-
vidual meetings of the committee, but membership
of the Committee must include patient/service user
representation, a representative of the Trust’s
Caldicott Guardian, Trust research and development
Figure 3 Screen shot of the South London and Maudsley NHS Trust Consent for Contact model (SLaM C4C) Patient
Participation Form in the original source Electronic Health Record (EHR; part II).
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(R&D) representation, and child and adolescent
mental health services (CAMHS) representation. The
Oversight Committee, its structure and its function
are an integral component of the CRIS data resource
as ethically approved.
▸ The Oversight Committee uses ethical, legal and sci-
entiﬁc criteria to adjudicate such access and use.
Applications to use CRIS to identify potential recruits
are considered only for projects that have speciﬁc
ethics and research governance approval. (In other
words, projects using the SLaM C4C model must ﬁrst
acquire ethics and research governance approval and
then approval from the Oversight Committee.) In the
UK, acquiring this approval necessitates specifying
how exactly patients will be recruited. This provides
an additional layer of oversight, which helps to
ensure that appropriate modes of approach are made
to patients who have given ‘consent for contact’ when
the topic of research is sensitive (eg, researchers
might be required to talk to the treating clinician
before contacting the patient).
▸ The recruiter submits the pseudonymised BRC ID of
potential recruits they wish to contact to a trusted
third party (TTP) appointed and monitored by the
Oversight Committee.
▸ The TTP has project-speciﬁc access to the database
linking the BRC IDs with the source EHR IDs.
Technical speciﬁcations within the system ensure that
CRIS cannot return the EHR ID of any patient who
has not given consent for contact. Following reverse
search, the TTP passes the EHR IDs of the potential
recruits that have given consent back to the recruiter.
▸ The recruiter, through the SLaM EHR, is then able
to identify and contact the patient to discuss partici-
pation in the project. Safeguards include a time limit
on when the recruiter may contact patients about
recruitment, and the requirement that recruiters
inform each patient’s care coordinator by email that
they will be contacting that patient in a few days’ time
(eg, to allow the opportunity for the care coordinator
to suggest that an approach at the current time might
not be advisable).
▸ The Oversight Committee monitors the research par-
ticipation forms to ascertain if approaches for research
participation or actual research participation appear
excessive. What would constitute ‘excessive’ is an
ethical, sociological and scientiﬁc question: what might
be excessive for certain individual patients, or groups of
patients, might not be for others; participating in mul-
tiple surveys might be adjudicated differently from par-
ticipation in several clinical trials in a short time frame.
The Oversight Committee is formalising guidelines to
adjudicate and respond to putatively ‘excessive’
research participation. Options for action include con-
tacting the patient or clinical team about whether the
patient continues to be willing to be approached about
further research projects during the course of the
current projects in which they are participating.
Involving and engaging stakeholders
There is increasing acknowledgement of the importance
of engaging stakeholders and the public in designing
ethical and technically robust procedures to guide the
use of EHRs.8 10 11 32 Mental health service users and
patients made signiﬁcant contributions to the develop-
ment of our model. The Patient and Carer Participation
Theme within the SLaM BRC took a central role in
developing the model; the Oversight Committee is
chaired by a mental health patient; and consultation
and engagement with service user/patient groups have
taken place throughout, in line with our BRC’s model of
involving service users/patients at all stages of transla-
tional research.33 An annual newsletter is sent to all
persons in the recruitment database summarising key
ﬁndings arising from the SLaM BRC, in addition to
reminding people of contact details for the database
(eg, if they wish later to withdraw). The SLaM C4C
model has a dedicated website, and there are regular
dissemination activities within the Trust to publicise the
model. Details of how to contact the SLaM C4C team
(who assist with requests to join the register, as well as
provide information on how to withdraw from the regis-
ter) are also disseminated online and via other media.
Those who consented to join the register but have been
discharged from the Trust are regularly sent a reminder
that they are on the register as well as information on
how to withdraw if they wish. As of July 2014, 30 patients
have withdrawn their consent from being listed on the
register (see box 2 for a summary of key features of the
SLaM C4C model).
RESULTS
Summary statistics from the implementation of SLaM C4C
SLaM C4C started to be implemented across the South
London and Maudsley NHS Trust in May 2012, and the
Box 2 Key features of the South London and Maudsley
NHS Trust Consent for Contact (SLaM C4C) model
▸ Extensive patient involvement throughout model’s
development.
▸ The initial contact is made by a member of the patient’s clin-
ical care team.
▸ Researchers gain access to identifiable information only for
patients who have given prior consent.
▸ All recruiting researchers have undergone extensive vetting
procedures, and are employed on contracts that have the
same level of duties and responsibilities (and same potential
penalties re disciplinary action and dismissal) as those with
substantive clinical contracts.
▸ Patients revisit their consent to be part of the recruitment data-
base on discharge from the service.
▸ Regular (at least yearly) engagement with those consenting to
be part of the recruitment database—about ongoing research
studies, as well as reminders about their consenting to be part
of the recruitment database and details on how to withdraw
consent.
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aim is to implement C4C across the entire Trust, which
serves a total of approximately 35 000 active patients,
split across seven clinical academic groups. All patients
are gradually being approached and asked whether they
will provide ‘consent for contact’. There are no exclu-
sion criteria. Implementation started in services where
there was already support for and/or enthusiasm about
C4C. The ﬁgures from 25 October 2013 show that a
total of 2106 patients had been approached, of whom
1560 had given consent and 546 had not: a 74.1%
consent rate. Table 1 presents descriptive statistics, from
October 2013, of those approached to give consent for
contact, in relation to gender, ethnicity and age.
DISCUSSION
Initial data suggest that the SLaM C4C model is capable
of accelerating the development of a culture of active
research participation that is founded on the ethical and
effective use of EHRs. The model has been successfully
developed with signiﬁcant patient/service user involve-
ment, has received necessary approval and endorsement
from all relevant governance bodies, and is currently
resulting in almost three of every four patients
approached agreeing to join the recruitment database.
Public surveys and bioethical analyses commonly indi-
cate that mental health is a sensitive domain in relation
to EHRs, in light of concerns about potential stigma and
discrimination.32 34 35 The current consent ﬁgures in
this secondary mental health services context are there-
fore encouraging vis-à-vis the model’s transferability
elsewhere.
Preliminary data from the implementation of SLaM
C4C raise some interesting lines of investigation. That
there are currently lower rates of consent from patients
over 75 concurs with other research that indicates that
older people are more likely to refuse participation in
health research.36 That there are currently higher rates
of consent by men than women parallels other ﬁndings
indicating that men are more likely to consent than
women to a review of their medical records.35 Variations
in consent rates pose questions about possible selection
bias in studies using this recruitment database. More
research is needed to assess how many of those giving
consent for contact subsequently consent to participate
in particular research studies. Studies currently under-
way that are using the SLaM C4C model to recruit parti-
cipants include: a longitudinal study to discover and
validate biomarkers in Alzheimer’s disease; an interven-
tional randomised, double-blind exploratory study inves-
tigating the effects of an atypical antidepressant on
cognition and BOLD fMRI signals in participants remit-
ted from depression and controls; a study examining dif-
ferences in cognitive appraisals of anomalous
experiences and different facial emotions at a cognitive
and neural level between individuals with psychotic
symptoms with a need for care versus those without a
need for care; and a study aiming prospectively to valid-
ate a set of questionnaires for the monitoring of treat-
ment outcomes and side effects (including suicidality
and self-harm) in general populations and in popula-
tions known to be at elevated risk of suicide.
The model that we have presented adheres to current
best practice in recruiting patients,24 most notably as
regards ensuring that no identiﬁable patient informa-
tion is available to researchers without the patient’s
consent. The model appears to be effective in its imple-
mentation—both in enabling the creation of a recruit-
ment database, and in terms of acceptability to patients.
We believe the model to be generalisable to other
health services contexts that employ EHRs. Our intent
when designing it was to guard against the erosion of
trust in research—a key risk associated with the use of
medical records without consent34—both through
adhering to consent for contact principles (ie, ensuring
that patients are explicitly asked for their consent before
their medical records can be looked at for research pur-
poses) and committing regularly to engage with
members of the recruitment database about ongoing
research and about their current willingness to be con-
tacted about potential research possibilities. We
designed the model to allow patients greater autonomy
in decisions to take part in research, through lessening
the gatekeeper role of clinicians: evidence from a pro-
spective cohort study and a qualitative process evaluation
indicates that such gatekeeper functions can impede
equitable access to research.13 37
Table 1 Descriptive data regarding patients approached
for SLaM C4C
Total,
(N)
Consenting,
(N)
Consent
rate (%)
Gender
Male 1078 844 78.3
Female 1028 716 69.6
Self-assigned ethnicity (amalgamated)
Caucasian 1228 894 72.8
Caribbean, African
or any other black
background
496 360 72.6
Not stated 205 168 82.0
Other 100 78 78.0
Indian, Pakistani,
Bangladeshi or any
other Asian
background
77 60 77.9
Age*
0–19 841 667 79.3
20–29 182 165 90.7
30–44 232 213 91.8
45–74 370 283 76.5
75+ 481 232 48.2
Data captured on 25 October 2013.
*Age distribution is not representative of the Trust as a whole,
since implementation of SLaM C4C to date has significantly
focused on Mental Health of Older Adults Services, and Child
and Adolescent Mental Health Services.
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A new culture of research participation?
The use, linkage and further development of large
EHR data sets are likely to transform relations between
researchers, clinicians, patients and their data. The
implementation of SLaM C4C, across a large mental
health provider, generates, we believe, effectively a ﬁeld
site or laboratory in which to study these potential
transformations. The Oversight Committee regularly
captures descriptive data that give broad indications of
how implementation of SLaM C4C is proceeding (both
as regards patients approached, and as regards the
number and type of research studies applying to use
SLaM C4C). In addition, SLaM BRC is planning add-
itional research and evaluation studies (see box 3 for
indicative research studies that address important ques-
tions associated with the use of EHRs for health
research).32 35
Our BRC’s ongoing collection of survey and audit data,
as well as planned research studies, comprise a powerful
means through which to interrogate and analyse the
sociological, ethical, technical and governance-related
ramiﬁcations of large-scale EHR implementation of
consent for contact, in which clinicians no longer
provide the primary conduit for patient participation in
research.
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